Rituximab is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light and heavy-chain variable region sequences and human constant region sequences , . It was originally approved by the U...
Rituximab is indicated for the treatment of adult patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin’s Lymphoma (NHL) as a single agent. Also, it is indicated for the treatment of adult patients with previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in pat...
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Auhui, China
Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo., Ulm, Germany
Kaiser Permanente Medical Ctr, Vallejo, California, United States
St. Luke's Hospital, Chesterfield, Missouri, United States
Northside Hospital, Atlanta, Georgia, United States
M D Anderson Cancer Center, Houston, Texas, United States
Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Luebeck, Germany
Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Germany
Hospital Regional Universitario de Malaga, Malaga, Spain
Washington University School of Medicine, Saint Louis, Missouri, United States
Research Site, Manchester, United Kingdom
Reumacentrum Genk, Genk, Limburg, Belgium
ZNA Jan Palfijn, Merksem, Antwerpen, Belgium
OLV Aalst, Aalst, Oost-Vlaanderen, Belgium
Bristol Royal Hospital for Children, Bristol, United Kingdom
Royal Manchester Children's Hospital, Manchester, United Kingdom
Birmingham Children's Hospital, Birmingham, United Kingdom
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.